ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home WCLC 2020 Archive

Acute Admissions Rates for Lung Cancer Patients Up During Pandemic, Not Linked to COVID-19

on: February 05, 2021In: COVID, WCLC 2020 Archive
Acute Admissions Rates for Lung Cancer Patients Up During Pandemic, Not Linked to COVID-19

Data from a single-center study in Scotland suggested that there were more patients with lung cancer admitted acutely with cancer, non-COVID-19-related illness during the COVID-19 pandemic. “Early and late lockdown […] Read more


Modeling Analyses Show That Expansions in Lung Cancer Screening Guidelines to Better Capture Underrepresented Populations Still Need Work

Kara Nyberg, PhD
on: February 05, 2021In: Screening/ED, WCLC 2020 Archive
Modeling Analyses Show That Expansions in Lung Cancer Screening Guidelines to Better Capture
            Underrepresented Populations Still Need Work

Two abstracts presented at the 2020 World Conference on Lung Cancer shed light on how changes in current screening guidelines can influence lung cancer detection rates, specifically among underrepresented populations. […] Read more

Young Investigators Awarded Grants to Study COVID-19 and Lung Cancer

on: February 05, 2021In: Behind the Scenes, WCLC 2020 Archive
Young Investigators Awarded Grants to Study COVID-19 and Lung Cancer

Lung Ambition Alliance to award four new Junior Faculty Research Grants. Four early-career researchers have been selected to receive the Lung Ambition Alliance Junior Faculty Grants for the Study of […] Read more

Lung Ambition Alliance: Stronger Together 

on: February 05, 2021In: Behind the Scenes, WCLC 2020 Archive
Lung Ambition Alliance: Stronger Together 

The IASLC has formed an alliance with the Global Lung Cancer Coalition (GLCC), Guardant Health, and AstraZeneca to accelerate the pace of lung cancer survival worldwide. This collaborative effort—known as […] Read more

Use of Predictive Biomarkers, Incorporating Chemotherapy—What Is Best When Using Immunotherapy in Advanced NSCLC?

Kara Nyberg, PhD
on: February 05, 2021In: Immunotherapy, WCLC 2020 Archive
Use of Predictive Biomarkers, Incorporating Chemotherapy—What Is Best When Using Immunotherapy in
            Advanced NSCLC?

Oncologists currently have three main therapeutic strategies to choose from when managing patients with advanced NSCLC who lack targetable mutations: immunotherapy alone, immunotherapy-immunotherapy combinations, or immunotherapy-chemotherapy combinations. So how does […] Read more

Patient Advocate Comment: Amivantamab for Exon 20

Marcia K. Horn, JD
on: January 31, 2021In: WCLC 2020 Archive
Patient Advocate Comment: Amivantamab for Exon 20

Amivantamab for Exon 20-Related NSCLC: Excitement in the Patient Community We look forward to Dr. Joshua Sabari’s presentation during the oral abstract presentation session “OA04: new Data from Rare EGFR […] Read more

Presidential Symposium Findings 

on: January 30, 2021In: WCLC 2020 Archive
Presidential Symposium Findings 

Read the full articles for detailed summaries of each presentation.  TALENT: This national lung cancer screening study conducted in Taiwan in 12,011 individuals, uncovered the presence of lung cancer in […] Read more

KEYNOTE-598: Dual PD-1 and CTLA-4 Checkpoint Blockade Confers No Therapeutic Benefit Beyond PD-1 Blockade Alone in PD-L1–Positive NSCLC

Kara Nyberg, PhD
on: January 28, 2021In: Presidential Symposium, WCLC 2020 Archive
KEYNOTE-598: Dual PD-1 and CTLA-4 Checkpoint Blockade Confers No Therapeutic Benefit Beyond PD-1 Blockade
            Alone in PD-L1–Positive NSCLC

Patients with metastatic NSCLC with a PD-L1 tumor proportion score (TPS) ≥ 50% face greater toxicity without the benefit of enhanced efficacy when ipilimumab is combined with pembrolizumab in the […] Read more

LCMC3 Findings Indicate Neoadjuvant Atezolizumab Safe, Efficacious in Resectable Stage IB-IIIB NSCLC

Kara Nyberg, PhD
on: January 28, 2021In: Presidential Symposium, WCLC 2020 Archive
LCMC3 Findings Indicate Neoadjuvant Atezolizumab Safe, Efficacious in Resectable Stage IB-IIIB NSCLC

Primary results of the phase II Lung Cancer Mutation Consortium (LCMC) 3 clinical trial suggest that neoadjuvant atezolizumab may be a worthwhile treatment option for selected patients with resectable stage […] Read more

Lung Cancer Screening Study in East Asia Successful at Identifying Early-Stage Disease

on: January 27, 2021In: Screening/ED, WCLC 2020 Archive
Lung Cancer Screening Study in East Asia Successful at Identifying Early-Stage Disease

TALENT, a national lung cancer screening study conducted in Taiwan in 12,011 individuals, uncovered the presence of lung cancer in 2.6% of the study population (Abstract PS01.02). These results are […] Read more

1234
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy